Prognostic Value of Lymph Node Ratio in Patients with Resected Synchronous Colorectal Liver Metastases and Less Than 12 Examined Lymph Nodes
暂无分享,去创建一个
V. Herlea | I. Popescu | F. Selaru | S. Alexandrescu | R. Grigorie | N. Zarnescu | D. Blăniţă | A. Diaconescu | Cristian A. Zlate
[1] A. Ruzzenente,et al. Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[2] J. Vauthey,et al. Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. , 2020, Hepatobiliary surgery and nutrition.
[3] B. Xing,et al. Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases , 2019, BMC surgery.
[4] D. Dai,et al. Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer , 2019, Front. Oncol..
[5] Z. Pan,et al. Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection , 2018, Cancer management and research.
[6] S. Katz,et al. Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer. , 2017, Hepatobiliary surgery and nutrition.
[7] Jan Sundquist,et al. Patterns of metastasis in colon and rectal cancer , 2016, Scientific Reports.
[8] L. Påhlman,et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2015, Cancer treatment reviews.
[9] C. Verhoef,et al. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[10] T. Ozawa,et al. Prognostic Significance of the Lymph Node Ratio in Stage IV Colorectal Cancer Patients who have Undergone Curative Resection , 2015, Annals of Surgical Oncology.
[11] Shan Wang,et al. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined , 2014, Tumor Biology.
[12] K. Søreide,et al. Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[13] Shung-Haur Yang,et al. The Impact of the Lymph Node Ratio is Greater than Traditional Lymph Node Status in Stage III Colorectal Cancer Patients , 2013, World Journal of Surgery.
[14] Jian-Wei Liu,et al. Prognostic value of the lymph node ratio in stage III colorectal cancer , 2012, Chinese journal of cancer.
[15] H. Friess,et al. The Prognostic Value of Lymph Node Ratio in a Population-Based Collective of Colorectal Cancer Patients , 2010, Annals of surgery.
[16] M. Choti,et al. Timing of Multimodality Therapy for Resectable Synchronous Colorectal Liver Metastases: A Retrospective Multi-Institutional Analysis , 2009, Annals of Surgical Oncology.
[17] B. Gustavsson,et al. A study of lymph node ratio in stage IV colorectal cancer , 2008, World journal of surgical oncology.
[18] J. Birkmeyer,et al. Hospital lymph node examination rates and survival after resection for colon cancer. , 2007, JAMA.
[19] M. Makuuchi,et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. , 2006, Archives of surgery.
[20] P. Catalano,et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] I. Popescu,et al. Metastatic colorectal cancer--what about the primary? , 2012, Acta chirurgica Iugoslavica.